{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:30:50Z","timestamp":1779114650961,"version":"3.51.4"},"reference-count":117,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1077931, APP1049148, APP1024467, APP1010315"],"award-info":[{"award-number":["APP1077931, APP1049148, APP1024467, APP1010315"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001069","name":"Women and Infants Research Foundation","doi-asserted-by":"publisher","award":["Capacity Building"],"award-info":[{"award-number":["Capacity Building"]}],"id":[{"id":"10.13039\/501100001069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012155","name":"Channel 7 Telethon Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012155","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00111","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T13:00:22Z","timestamp":1459515622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy"],"prefix":"10.3389","volume":"7","author":[{"given":"Jeffrey A.","family":"Keelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew W.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demelza J.","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Newnham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","article-title":"An overview of mortality and sequelae of preterm birth from infancy to adulthood","volume":"371","author":"Saigal","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.puhe.2014.03.010","article-title":"Outcomes in preterm infants","volume":"128","author":"Platt","year":"2014","journal-title":"Public Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(14)70710-8","article-title":"Infection-induced inflammation and cerebral injury in preterm infants","volume":"14","author":"Strunk","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"450.e1","DOI":"10.1016\/j.ajog.2013","article-title":"Prenatal inflammation is associated with adverse neonatal outcomes","volume":"210","author":"Bastek","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJM200005183422007","article-title":"Intrauterine infection and preterm delivery","volume":"342","author":"Goldenberg","year":"2000","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0095-5108(03)00101-5","article-title":"The epidemiology of preterm birth","volume":"30","author":"Iams","year":"2003","journal-title":"Clin Perinatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2006-956773","article-title":"The role of inflammation and infection in preterm birth","volume":"25","author":"Romero","year":"2007","journal-title":"Semin Reprod Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/labinvest.2009.49","article-title":"Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amniotic infection","volume":"89","author":"Kim","year":"2009","journal-title":"Lab Invest"},{"issue":"4","key":"B9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/aji.12189","article-title":"A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes","volume":"71","author":"Romero","year":"2014","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1515\/jpm-2015-0045","article-title":"Clinical chorioamnionitis at term II: the intra-amniotic inflammatory response","volume":"44","author":"Romero","year":"2015","journal-title":"J Perinat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"125.e1","DOI":"10.1016\/j.ajog.2013.11.032","article-title":"Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes","volume":"210","author":"Combs","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/aji.12296","article-title":"Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes","volume":"72","author":"Romero","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1515\/jpm-2014-0249","article-title":"Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques","volume":"43","author":"Romero","year":"2015","journal-title":"J Perinat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.siny.2011.10.001","article-title":"Diversity of microbes in amniotic fluid","volume":"17","author":"DiGiulio","year":"2012","journal-title":"Semin Fetal Neonatal Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1055\/s-0033-1361830","article-title":"Microbiome in parturition and preterm birth","volume":"32","author":"Mysorekar","year":"2014","journal-title":"Semin Reprod Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2049-2618-2-18","article-title":"The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term","volume":"2","author":"Romero","year":"2014","journal-title":"Microbiome"},{"key":"B17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-0897.2010.00830.x","article-title":"Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes","volume":"64","author":"DiGiulio","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fcimb.2013.00058","article-title":"Bacterial aetiological agents of intra-amniotic infections and preterm birth in pregnant women","volume":"3","author":"Mendz","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s10096-006-0190-3","article-title":"Preterm birth due to maternal infection: causative pathogens and modes of prevention","volume":"25","author":"Pararas","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fimmu.2014.00595","article-title":"Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome","volume":"5","author":"Payne","year":"2014","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.1251816","article-title":"Preterm labor: one syndrome, many causes","volume":"345","author":"Romero","year":"2014","journal-title":"Science"},{"issue":"12","key":"B22","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3109\/14767058.2014.958463","article-title":"Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes","volume":"28","author":"Romero","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/QCO.0b013e328360db58","article-title":"Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes","volume":"26","author":"Capoccia","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/14767058.2013.818124","article-title":"Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes","volume":"27","author":"Kwak","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ogc.2014.08.010","article-title":"The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes","volume":"41","author":"Murtha","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"key":"B26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.diagmicrobio.2009.12.023","article-title":"The bacterial load of Ureaplasma parvum in amniotic fluid is correlated with an increased intrauterine inflammatory response","volume":"67","author":"Kasper","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0029-7844(95)00376-2","article-title":"Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely","volume":"87","author":"Kundsin","year":"1996","journal-title":"Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejogrb.2006.09.013","article-title":"Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants","volume":"134","author":"Kirchner","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1515\/JPM.2010.040","article-title":"Detection of Ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency","volume":"38","author":"Oh","year":"2010","journal-title":"J Perinat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fimmu.2014.00574","article-title":"Preterm birth, intrauterine infection, and fetal inflammation","volume":"5","author":"Kemp","year":"2014","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1177\/1933719111408114","article-title":"Inflammation of the fetal ovine skin following in utero exposure to Ureaplasma parvum","volume":"18","author":"Kemp","year":"2011","journal-title":"Reprod Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"475.e1","DOI":"10.1016\/j.ajog.2012.10.871","article-title":"Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model","volume":"207","author":"Grigsby","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/1933719108325508","article-title":"Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques","volume":"16","author":"Novy","year":"2009","journal-title":"Reprod Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/JCM.01206-08","article-title":"Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth","volume":"47","author":"Han","year":"2009","journal-title":"J Clin Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3389\/fimmu.2015.00566","article-title":"Advances in the prevention of infection-related preterm birth","volume":"16","author":"Lamont","year":"2015","journal-title":"Front Inflamm"},{"key":"B36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1479-828X.2007.00816.x","article-title":"Antibiotics for the prevention of preterm birth","volume":"48","author":"Bujold","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1479-828X.2007.00759.x","article-title":"Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis","volume":"47","author":"Simcox","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1701-2163(16)32350-7","article-title":"The effect of second-trimester antibiotic therapy on the rate of preterm birth","volume":"29","author":"Morency","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"B39","doi-asserted-by":"publisher","first-page":"CD000262","DOI":"10.1002\/14651858.CD000262.pub4","article-title":"Antibiotics for treating bacterial vaginosis in pregnancy","volume":"1","author":"Brocklehurst","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ogc.2011.12.007","article-title":"Antibiotics in the management of PROM and preterm labor","volume":"39","author":"Mercer","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"key":"B41","doi-asserted-by":"publisher","first-page":"CD002250","DOI":"10.1002\/14651858.CD002250.pub3","article-title":"Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity","volume":"6","author":"Thinkhamrop","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e82599","DOI":"10.1371\/journal.pone.0082599","article-title":"Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process","volume":"8","author":"Lambert","year":"2013","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2007.01.001","article-title":"Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy","volume":"21","author":"Ugwumadu","year":"2007","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"B44","doi-asserted-by":"publisher","first-page":"CD000262","DOI":"10.1002\/14651858.CD000262.pub3","article-title":"Antibiotics for treating bacterial vaginosis in pregnancy","author":"McDonald","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajog.2011.03.047","article-title":"Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis","volume":"205","author":"Lamont","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/1471-2393-14-340","article-title":"Second trimester amniotic fluid cytokine concentrations, Ureaplasma sp. colonisation status and sexual activity as predictors of preterm birth in Chinese and Australian women","volume":"14","author":"Payne","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/1469-0691.12686","article-title":"Treatment of genital Mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications","volume":"20","author":"Vouga","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"B48","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1128\/AAC.03187-14","article-title":"Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection","volume":"58","author":"Miura","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B49","first-page":"202","article-title":"Effect on birth weight of erythromycin treatment of pregnant women","volume":"69","author":"McCormack","year":"1987","journal-title":"Obstet Gynecol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1520-6661(199901\/02)8:112::AID-MFM33.0.CO;2-8","article-title":"Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery","volume":"8","author":"Ogasawara","year":"1999","journal-title":"J Matern Fetal Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14767050601135485","article-title":"Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection","volume":"20","author":"Gomez","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"134.e131","DOI":"10.1016\/j.ajog.2014.02.025","article-title":"Repeated maternal intramuscular or intraamniotic erythromycin incompletely resolves intrauterine Ureaplasma parvum infection in a sheep model of pregnancy","volume":"211","author":"Kemp","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1471-0528.2000.tb13339.x","article-title":"The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin","volume":"107","author":"Heikkinen","year":"2000","journal-title":"Br J Obstet Gynaecol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJM197306072882307","article-title":"Transplacental passage of erythromycin and clindamycin","volume":"288","author":"Philipson","year":"1973","journal-title":"N Engl J Med"},{"issue":"546","key":"B55","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/j.ajog.2011.02.035","article-title":"Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep","volume":"204","author":"Keelan","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S2213-2600(15)00188-5","article-title":"Solithromycin to treat community-acquired pneumonia?","volume":"3","author":"Mushtaq","year":"2015","journal-title":"Lancet Respir Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1586\/14787210.2016.1138857","article-title":"The role of solithromycin in the management of bacterial community-acquired pneumonia","volume":"14","author":"Van Bambeke","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1128\/AAC.04568-14","article-title":"Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012","volume":"59","author":"Farrell","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1128\/AAC.02210-13","article-title":"In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae","volume":"58","author":"Piccinelli","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B60","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1128\/AAC.01639-13","article-title":"Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1","volume":"58","author":"Mallegol","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1128\/AAC.02411-14","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1128\/AAC.02316-12","article-title":"Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae","volume":"57","author":"Rodgers","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00564-13","article-title":"Determination of in vitro activity of solithromycin at different pHs and its intracellular activity tested against clinical isolates of Neisseria gonorrhoeae from a laboratory collection","author":"Mallegol","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B64","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1128\/AAC.05039-11","article-title":"In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species","volume":"56","author":"Wittlin","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1128\/AAC.00036-12","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea?","volume":"56","author":"Golparian","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B66","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijantimicag.2010.08.021","article-title":"Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci","volume":"37","author":"Putnam","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"B67","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jinf.2010.08.010","article-title":"The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)","volume":"61","author":"Farrell","year":"2010","journal-title":"J Infect"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1128\/AAC.01429-10","article-title":"Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects","volume":"55","author":"Still","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"B69","first-page":"O95","article-title":"A phase 1 trial to evaluate the safety and pharmacokinetics of single doses of intravenous (IV) solithromycin (CEM-101) in healthy adult subjects","volume-title":"21st European Congress of Clinical Microbiology of Infectious Diseases","author":"Schranz","year":"2011"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1128\/AAC.00766-12","article-title":"Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects","volume":"56","author":"Rodvold","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1128\/AAC.00203-09","article-title":"Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages","volume":"53","author":"Lemaire","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B72","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/AAC.00860-10","article-title":"Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis","volume":"54","author":"Llano-Sotelo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B73","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1128\/AAC.02085-15","article-title":"Type 3 secretion-dependent sensitivity of Escherichia coli O157 to specific ketolides","volume":"60","author":"Fernandez-Brando","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1128\/AAC.00090-09","article-title":"Comparative in vitro susceptibilities of human Mycoplasmas and Ureaplasmas to a new investigational ketolide, CEM-101","volume":"53","author":"Waites","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B75","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijantimicag.2015.04.015","article-title":"In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin","volume":"46","author":"Furfaro","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"B76","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1128\/AAC.01123-09","article-title":"In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms","volume":"54","author":"McGhee","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1128\/AAC.01343-09","article-title":"In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae","volume":"54","author":"Roblin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1128\/AAC.00197-13","article-title":"Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia","volume":"57","author":"Oldach","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/civ478","article-title":"A phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea","volume":"61","author":"Hook","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1128\/AAC.04652-14","article-title":"Safety and pharmacokinetics of solithromycin in subjects with hepatic impairment","volume":"59","author":"Jamieson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.placenta.2014.09.009","article-title":"Trans-placental passage and anti-inflammatory effects of solithromycin in the human placenta","volume":"35","author":"Keelan","year":"2014","journal-title":"Placenta"},{"key":"B82","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/AAC.01743-13","article-title":"Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model","volume":"58","author":"Keelan","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1128\/AAC.01691-12","article-title":"Fetal safety of macrolides","volume":"57","author":"Bahat Dinur","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"B84","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/pds.3900","article-title":"Use of macrolides during pregnancy and the risk of birth defects: a population-based study","volume":"24","author":"Berard","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B85","doi-asserted-by":"publisher","first-page":"g1908","DOI":"10.1136\/bmj.g1908","article-title":"Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study","volume":"348","author":"Lund","year":"2014","journal-title":"BMJ"},{"key":"B86","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1542\/peds.2014-2026","article-title":"Azithromycin in early infancy and pyloric stenosis","volume":"135","author":"Eberly","year":"2015","journal-title":"Pediatrics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"g5201","DOI":"10.1136\/bmj.g5201","article-title":"The difficulty in evaluating all findings in study on use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis","volume":"349","author":"de Vries","year":"2014","journal-title":"BMJ"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-0114-6","article-title":"No association between macrolide treatment in infancy and later pyloric stenosis in Sweden","author":"Ludvigsson","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.reprotox.2005.01.010","article-title":"Is erythromycin therapy teratogenic in humans?","volume":"20","author":"Kallen","year":"2005","journal-title":"Reprod Toxicol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","article-title":"Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study","volume":"163","author":"Crider","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"221","key":"B91","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.ajog.2012.12.023","article-title":"Safety of macrolides during pregnancy","volume":"208","author":"Lin","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-0033-1361825","article-title":"Early development of the gut microbiome and immune-mediated childhood disorders","volume":"32","author":"Li","year":"2014","journal-title":"Semin Reprod Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.molmed.2014.12.002","article-title":"The infant microbiome development: mom matters","volume":"21","author":"Mueller","year":"2015","journal-title":"Trends Mol Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1055\/s-0033-1361818","article-title":"The microbiome and development: a mother\u2019s perspective","volume":"32","author":"Prince","year":"2014","journal-title":"Semin Reprod Med"},{"issue":"Suppl 2","key":"B95","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/14767058.2013.829700","article-title":"Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy","volume":"26","author":"Faa","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/ijo.2014.119","article-title":"Infant antibiotic exposure and the development of childhood overweight and central adiposity","volume":"38","author":"Azad","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13601","article-title":"Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study","author":"Azad","year":"2015","journal-title":"Br J Obstet Gynaecol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.anai.2014.11.014","article-title":"Relationship between prenatal antibiotic use and asthma in at-risk children","volume":"114","author":"Lapin","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrendo.2014.210","article-title":"Antibiotics in early life and obesity","volume":"11","author":"Cox","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/cea.12356","article-title":"Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood","volume":"45","author":"Mets\u00e4l\u00e4","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"B101","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fimmu.2015.00166","article-title":"Drugs to block cytokine signaling for the prevention and treatment of inflammation-induced preterm birth","volume":"6","author":"Ng","year":"2015","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jri.2010.11.003","article-title":"Pharmacological inhibition of inflammatory pathways for the prevention of preterm birth","volume":"88","author":"Keelan","year":"2011","journal-title":"J Reprod Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/molehr\/gav005","article-title":"Intra-amniotic pharmacological blockade of inflammatory signalling pathways in an ovine chorioamnionitis model","volume":"21","author":"Ireland","year":"2015","journal-title":"Mol Hum Reprod"},{"key":"B104","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1530\/REP-13-0576","article-title":"Effects of cytokine-suppressive anti-inflammatory drugs on inflammatory activation in ex vivo human and ovine fetal membranes","volume":"147","author":"Stinson","year":"2014","journal-title":"Reproduction"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1476-5381.2010.00839.x","article-title":"Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-kappaB kinase (IKK) inhibitors","volume":"160","author":"De Silva","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/bph.12187","article-title":"A novel macrolide\/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition","volume":"169","author":"Kobayashi","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1124\/jpet.112.200733","article-title":"A novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-kappaB inhibition","volume":"345","author":"Kobayashi","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"B108","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/09273940903359725","article-title":"Anti-inflammatory activity of azithromycin as measured by its NF-kappaB, inhibitory activity","volume":"18","author":"Cheung","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1128\/AAC.48.5.1581-1585.2004","article-title":"Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation","volume":"48","author":"Desaki","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"B110","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/bbrc.1999.1917","article-title":"Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells","volume":"267","author":"Desaki","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B111","doi-asserted-by":"publisher","first-page":"776.e1","DOI":"10.1016\/j.ajog.2015.03.052","article-title":"Women with preterm birth have a distinct cervicovaginal metabolome","volume":"212","author":"Ghartey","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/1933719113488838","article-title":"Diversity of the vaginal microbiome correlates with preterm birth","volume":"21","author":"Hyman","year":"2013","journal-title":"Reprod Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jri.2014.03.006","article-title":"The microbiome, parturition, and timing of birth: more questions than answers","volume":"104\u2013105","author":"Prince","year":"2014","journal-title":"J Reprod Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/uog.6437","article-title":"Cervical length and gestational age at admission as predictors of intra-amniotic inflammation in preterm labor with intact membranes","volume":"34","author":"Palacio","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/uog.3837","article-title":"Cervical length in women in preterm labor with intact membranes: relationship to \u00adintra-amniotic inflammation\/microbial invasion, cervical inflammation and preterm delivery","volume":"28","author":"Holst","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B116","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/JPM.2006.002","article-title":"A sonographic short cervix as the only clinical manifestation of intra-amniotic infection","volume":"34","author":"Hassan","year":"2006","journal-title":"J Perinat Med"},{"issue":"12","key":"B117","doi-asserted-by":"publisher","first-page":"CD001058","DOI":"10.1002\/14651858.CD001058.pub3","article-title":"Antibiotics for preterm rupture of membranes","author":"Kenyon","year":"2013","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T17:36:34Z","timestamp":1589650594000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":117,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00111","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}